The impact of oxygen saturation on functional performance in patients with COPD on long-term oxygen therapy - a randomized crossover trialShow others and affiliations
2024 (English)In: European Respiratory Journal, ISSN 0903-1936, E-ISSN 1399-3003, Vol. 64, no Suppl. 68, article id OA3695Article in journal, Meeting abstract (Other academic) Published
Abstract [en]
Background: Minimizing hypoxemia during submaximal test has a positive effect on exercise capacity and dyspnea in patients with COPD on long-term oxygen therapy (LTOT). However, the impact of optimizing oxygenation during everyday tasks remains unexplored. Therefore, we investigated the effects of maintaining a target saturation on Activities of Daily Living (ADL) using an automated oxygen system compared to conventional fixed oxygen flow.
Methods: In a double-blinded, randomized crossover trial, 31 patients with COPD on LTOT performed two Glittre-ADL tests to assess the functional performance of everyday activities using a) an adjusted flow from 0-8 L/min targeting a SpO2 of 90-94% and b) their fixed oxygen dose. An electronic device (O2matic HOT) automatically titrated the oxygen based on information from a Bluetooth wrist pulse oximeter.
Results: The patients reduced the time to perform the ADL-test by median (IQR) 38 (12-73) seconds, p<0.001, using automated titration compared to the fixed oxygen flow. The oxygen flow in the automated arm more than tripled to 5.4 (4.1 – 6.8) L/min vs. 1.6 (1.1-2.1) L/min (fixed) during the test, p<0.001, while the time spend within SpO2-target was increased from 24% to 47%, p<0.001. Correspondingly, the patients experienced less dyspnea (BorgCR10); 5 (3-7) vs. 6 (4-8), p<0.001. Twenty-seven (87%) patients exceeded the minimal clinical important difference (MCID) in either the change of dyspnea score or time difference to complete the ADL-test.
Conclusions: Extending the time spent within target saturation reduced dyspnea and improved functional performance in activities of daily living in patients with COPD on LTOT.
Place, publisher, year, edition, pages
European Respiratory Society , 2024. Vol. 64, no Suppl. 68, article id OA3695
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:oru:diva-117579DOI: 10.1183/13993003.congress-2024.OA3695ISI: 001356234300056OAI: oai:DiVA.org:oru-117579DiVA, id: diva2:1918935
Conference
European-Respiratory-Society Congress (ERS), Vienna, Austria, September 7-11, 2024
2024-12-062024-12-062025-04-30Bibliographically approved